if low doses of pergolide can reduce dopaminergic transmission by activating presynaptic receptors that control dopamine release , then this action might be therapeutically useful in treating schizophrenia without causing tardive dyskinesia or in the treatment of tardive dyskinesia .
C0282151
dopaminergic
C0013030
dopamine